Home > Insider Trading > Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc. (CYCC)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

13D Filing: Tang Capital Partners LP and Cyclacel Pharmaceuticals Inc. (CYCC)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240...

Keep Reading →

November 25th, 2017 - Hedge Funds

Why Cyclacel Pharmaceuticals Inc (CYCC) is in the Spotlight

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares have popped over 30% this afternoon due to momentum traders buying the stock for technical reasons.

Keep Reading →

April 4th, 2017 - Market Movers News

Here's What Is Happening In Financial Markets Today?

“Wall Street stocks on Monday were aiming to start the second quarter with tepid gains.

Keep Reading →

April 3rd, 2017 - Commodities Gold Market Movers News Tech

Here's What Happened With Cyclacel Pharmaceuticals Inc (CYCC) And Nivalis Therapeutics Inc (NVLS)

This week was a good one for a few biotechs, but not so great for others.

Keep Reading →

February 24th, 2017 - News Stock Analysis

Here's Why Cyclacel Pharmaceuticals Inc (CYCC) Could Have A Rough December

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) soared throughout the US session on Thursday, gaining as much as 60% across the day.

Keep Reading →

November 18th, 2016 - News Stock Analysis

Movers and Shakers In Biotech: Cyclacel Pharmaceuticals Inc (CYCC) and Corium International Inc (CORI)

Yet again, we’ve had a busy start to the week in biotech. A number of companies are moving on news or data reported at the close of last week, and others on fresh information this week.

Keep Reading →

August 23rd, 2016 - News Stock Analysis

Why Are Traders Piling Into These Stocks?

Crude futures are up more than 2% this morning as weakness in the dollar and supply disturbances boost sentiment.

Keep Reading →

June 6th, 2016 - Market Movers News

ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday's intraday trading and hit a 52-week high of $46.48.

Keep Reading →

March 10th, 2015 - Hedge Funds News

Tang Capital Management Is Getting Out of OncoGenex Pharmaceuticals Inc (OGXI) and Cyclacel Pharmaceuticals Inc (CYCC)

Kevin C. Tang's Tang Capital Management has decreased its position it two pharmaceutical companies.

Keep Reading →

January 17th, 2014 - Hedge Funds News

Jeremy Green, Redmile Group Drop Cyclacel Pharmaceuticals Like It's Hot

Jeremy Green, Redmile Group: In a passive 13G filing with the SEC just now, the San Francisco-based Redmile Group, managed by Jeremy Green, has closed out its position in Cyclacel Pharmaceuticals Inc...

Keep Reading →

October 3rd, 2013 - Hedge Funds News